Kindstar Globalgene Technology (HKSE:09960) Ending Cash Position : HK$636 Mil (As of Jun. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Kindstar Globalgene Technology Ending Cash Position?

Kindstar Globalgene Technology's Ending Cash Position for the quarter that ended in Jun. 2024 was HK$636 Mil.

Kindstar Globalgene Technology's quarterly Ending Cash Position increased from Jun. 2023 (HK$1,318 Mil) to Dec. 2023 (HK$1,611 Mil) but then declined from Dec. 2023 (HK$1,611 Mil) to Jun. 2024 (HK$636 Mil).

Kindstar Globalgene Technology's annual Ending Cash Position declined from Dec. 2021 (HK$2,200 Mil) to Dec. 2022 (HK$760 Mil) but then increased from Dec. 2022 (HK$760 Mil) to Dec. 2023 (HK$1,611 Mil).

Kindstar Globalgene Technology Ending Cash Position Historical Data

The historical data trend for Kindstar Globalgene Technology's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kindstar Globalgene Technology Ending Cash Position Chart

Kindstar Globalgene Technology Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

66.22

997.22

2,200.00

759.77

1,610.92

Kindstar Globalgene Technology Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial						677.24	759.77	1,317.64	1,610.92	636.39

Kindstar Globalgene Technology Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Kindstar Globalgene Technology's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	744.161	+	866.755
	=	1,611

Kindstar Globalgene Technology's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	1585.533	+	-949.139
	=	636

Kindstar Globalgene Technology Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Kindstar Globalgene Technology's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Kindstar Globalgene Technology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Kindstar Globalgene Technology Inc (HKSE:09960) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

Biolake D2-1, 666 Gaoxin Road, East Lake High Tech Zone, Hubei Province, Wuhan, CHN

Website

https://www.kindstar.com.cn

Kindstar Globalgene Technology Inc is principally engaged in the provision of clinical testing services in China. It organizes the business into the following segments; hematology testing, genetic disease and rare disease testing, infectious disease testing, oncology testing, neurology testing, maternity-related testing, COVID-19-related testing, routine testing, scientific research services and CRO, and other segments provide testing services for R&D projects and others and miscellaneous services.

Executives

Cpechina Fund Iii, L.p.	2201 Interest of corporation controlled by you
Ck Lab Tech Investment Limited	2101 Beneficial owner
Cpe Funds Iii Limited	2201 Interest of corporation controlled by you
Cpe Holdings International Limited	2201 Interest of corporation controlled by you
Cpe Holdings Limited	2201 Interest of corporation controlled by you
Huang Shiang	2101 Beneficial owner
Tu Zanbing
Huang Zuie-chin	2101 Beneficial owner
Ningbo Meishan Bonded Port Zone Ruifu Bojian Investment Management Co., Ltd.
Jackson Hole Trust Company
Huang Bo
Kernelstar Limited	2301 Trustee
Kastle Limited	2301 Trustee
Guo Gui-rong	2202 Interest of your spouse
Morningside Holdings (asia) Limited	2201 Interest of corporation controlled by you

Kindstar Globalgene Technology Headlines

No Headlines